Russell J. Cox - Net Worth and Insider Trading
Russell J. Cox Net Worth
The estimated net worth of Russell J. Cox is at least $6 Million dollars as of 2024-11-13. Russell J. Cox is the EVP & COO of Jazz Pharmaceuticals PLC and owns about 47,095 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $6 Million. Russell J. Cox is the Director of Spyre Therapeutics Inc and owns about 280 shares of Spyre Therapeutics Inc (SYRE) stock worth over $10,010. Russell J. Cox is also the Director of Gossamer Bio Inc and owns about 7,200 shares of Gossamer Bio Inc (GOSS) stock worth over $6,082. Details can be seen in Russell J. Cox's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Russell J. Cox has not made any transactions after 2019-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Russell J. Cox
Russell J. Cox Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Russell J. Cox owns 4 companies in total, including Gossamer Bio Inc (GOSS) , Spyre Therapeutics Inc (SYRE) , and Immunic Inc (IMUX) among others .
Click here to see the complete history of Russell J. Cox’s form 4 insider trades.
Insider Ownership Summary of Russell J. Cox
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GOSS | Gossamer Bio Inc | 2019-02-12 | director |
SYRE | Spyre Therapeutics Inc | 2016-04-12 | director |
IMUX | Immunic Inc | 2018-01-03 | director & Chief Executive Officer |
2017-01-18 | EVP & Chief Commercial Officer |
Russell J. Cox Latest Holdings Summary
Russell J. Cox currently owns a total of 3 stocks. Among these stocks, Russell J. Cox owns 47,095 shares of Jazz Pharmaceuticals PLC (JAZZ) as of January 18, 2017, with a value of $6 Million and a weighting of 99.73%. Russell J. Cox owns 280 shares of Spyre Therapeutics Inc (SYRE) as of April 12, 2016, with a value of $10,010 and a weighting of 0.17%. Russell J. Cox also owns 7,200 shares of Gossamer Bio Inc (GOSS) as of February 12, 2019, with a value of $6,082 and a weighting of 0.1%.
Latest Holdings of Russell J. Cox
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals PLC | 2017-01-18 | 47,095 | 127.70 | 6,014,032 |
SYRE | Spyre Therapeutics Inc | 2016-04-12 | 280 | 35.75 | 10,010 |
GOSS | Gossamer Bio Inc | 2019-02-12 | 7,200 | 0.84 | 6,082 |
Holding Weightings of Russell J. Cox
Russell J. Cox Form 4 Trading Tracker
According to the SEC Form 4 filings, Russell J. Cox has made a total of 0 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 4,000 shares on January 18, 2017, which brought Russell J. Cox around $515,000.
According to the SEC Form 4 filings, Russell J. Cox has made a total of 0 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years. The most-recent trade in Spyre Therapeutics Inc is the acquisition of 280 shares on April 12, 2016, which cost Russell J. Cox around $70,000.
According to the SEC Form 4 filings, Russell J. Cox has made a total of 0 transactions in Gossamer Bio Inc (GOSS) over the past 5 years. The most-recent trade in Gossamer Bio Inc is the acquisition of 7,200 shares on February 12, 2019, which cost Russell J. Cox around $115,200.
Insider Trading History of Russell J. Cox
- 1
Russell J. Cox Trading Performance
GuruFocus tracks the stock performance after each of Russell J. Cox's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Russell J. Cox is -25.76%. GuruFocus also compares Russell J. Cox's trading performance to market benchmark return within the same time period. The performance of stocks bought by Russell J. Cox within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Russell J. Cox's insider trading performs compared to the benchmark.
Performance of Russell J. Cox
Russell J. Cox Ownership Network
Ownership Network List of Russell J. Cox
Ownership Network Relation of Russell J. Cox
Russell J. Cox Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Russell J. Cox is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Russell J. Cox made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net sale of 7,740 shares made by Richard Aranda , and a net purchase of 348,828 shares made by Faheem Hasnain .
In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,790 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 681,210 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Russell J. Cox Mailing Address
Above is the net worth, insider trading, and ownership report for Russell J. Cox. You might contact Russell J. Cox via mailing address: C/o Jazz Pharmaceuticals, Plc, 5th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4 L2.